Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Aug;43(5):292-297.
doi: 10.1503/jpn.180128.

Who should be "controls" in studies on the neurobiology of psychiatric disorders?

Affiliations
Editorial

Who should be "controls" in studies on the neurobiology of psychiatric disorders?

Patricia Boksa et al. J Psychiatry Neurosci. 2018 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: See jpn.ca/about/ for editorial board member competing interests.

Similar articles

References

    1. Eichler HG, Bloechl-Daum B, Bauer P, et al. “Threshold-crossing”: A useful way to establish the counterfactual in clinical trials? Clin Pharmacol Ther. 2016;100:699–712. - PMC - PubMed
    1. McDonald C. Brain structural effects of psychopharmacological treatment in bipolar disorder. Curr Neuropharmacol. 2015;13:445–57. - PMC - PubMed
    1. Hajek T, Kopecek M, Höschl C, et al. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci. 2012;37:333–43. - PMC - PubMed
    1. Roiz-Santiañez R, Suarez-Pinilla P, Crespo-Facorro B. Brain structural effects of antipsychotic treatment in schizophrenia: a systematic review. Curr Neuropharmacol. 2015;13:422–34. - PMC - PubMed
    1. Huhtaniska S, Jääskeläinen E, Hirvonen N, et al. Long-term antipsychotic use and brain changes in schizophrenia — a systematic review and meta-analysis. Hum Psychopharmacol. 2017;32:e2574. - PubMed

Publication types

Substances